United Therapeutics Corporation · 16 hours ago
Director, Strategic Clinical Development
United Therapeutics Corporation is a pioneering biotech company focused on developing novel pharmaceutical therapies and technologies for organ transplants. The Director of Strategic Clinical Development will lead the clinical development strategy for assigned programs from inception to product approval, overseeing various clinical protocols and collaborating with cross-functional teams.
Responsibilities
Design and review clinical protocols, data analysis plans, interpretation of results, clinical study reports, and supporting work for sections of regulatory submissions, such as, INDs, CTAs, NDAs, MAAs and regulatory agency briefing packages, etc
Prepare, present, and defend complex aspects of protocol design and/or study data at investigator and internal meetings
Prepare and review draft abstracts and manuscripts for publication in consultation with other team members/collaborators
Assist in researching and drafting of sections or entire documents, as assigned, such as DSURs, other study reports and documents, investigator brochures, etc
Critically analyze and synthesize complex information from reviews of the scientific/clinical literature
Collaborate with Medical Science Liaisons and other company staff in identifying key partners for future research studies/projects
Manage and support Clinical Operations resources in evaluating, selecting, and engaging research-oriented investigative sites for company-sponsored studies and future research projects
Attend appropriate external scientific events to maintain awareness of research activities and represent a project and/or the company
Participate in cross-functional teams, departmental meetings, and regulatory meetings
Offer scientific insights into therapeutic areas and disease specific information as required
Qualification
Required
Doctor of Philosophy (PhD), PharmD, MPH, or RN in life sciences
10+ years of experience in pharmaceutical/biotech industry clinical research/development with a PhD or PharmD or
12+ years of experience in pharmaceutical/biotech industry clinical research/development with a MPH or RN
Experience with development of clinical trial protocols, CSRs, abstracts, and manuscripts
Experience in the preparation of regulatory applications (e.g. IND, CTA, NDA, MAA, and agency meeting packages)
Knowledge of GCP and regulatory guidelines
Knowledge of clinical science as applicable to drug development
Medical, scientific, and/or regulatory writing experience
Excellent interpersonal communication skills (written, verbal, and presentation)
Ability to thrive as both a manager and a team member
Ability to simultaneously manage activities associated with multiple clinical trials and programs with short timelines
Strong analytical skills
Ability to speak and write in English fluently
Attention to detail and a commitment to high quality and on-time deliverables are key success factors
Microsoft Office Suite
Ability to perform Literature searches for specific research questions and collate published literature in a succinct manner
Preferred
5+ years of experience in applied (clinical or discovery) research with a focus on pulmonary diseases
5+ years of experience in specialization in cardiopulmonary disease, such as, PH, COPD, IPF, CF, etc
Experience in making presentations to a wide audience on research conducted and authoring manuscripts
Experience in drug development for orphan diseases
Experience in Clinical development of Pulmonary diseases
Experience with creating and querying databases as assigned
Clinical research/development/specialty in cardio-pulmonary disease, such as, PH, COPD, IPF, CF, etc
Benefits
Medical / dental / vision / prescription coverage
Employee wellness resources
Savings plans (401k and ESPP)
Paid time off & paid parental leave benefits
Disability benefits
More
Company
United Therapeutics Corporation
Founded to find a cure for a daughter’s rare disease, United Therapeutics is a biotechnology company transforming care for people with chronic and life-threatening conditions.
Funding
Current Stage
Public CompanyTotal Funding
unknown1999-06-17IPO
Recent News
2025-12-29
NH Business Review
2025-11-11
Company data provided by crunchbase